Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Viewpoints - In Q3 2025, the company achieved a revenue of 910 million yuan, representing a year-on-year growth of 21%, and a net profit attributable to shareholders of 12.58 million yuan, reversing a loss of 24.02 million yuan [4][11]. - The strong growth of high-end brands, coupled with the expansion of offline channels, has accelerated revenue growth. However, due to increased investment in new product promotion and overall R&D, profitability experienced slight fluctuations [2][11]. - Looking ahead, the launch of the new "Yifidan" cream is anticipated, with the brand expected to achieve a comprehensive product layout. The PA and RV segments are gradually forming a second growth tier, indicating promising future growth for the group [2][11]. Summary by Sections Financial Performance - In Q3 2025, the company reported a revenue of 910 million yuan, a 21% increase year-on-year, and a net profit of 12.58 million yuan, marking a turnaround from a loss of 24.02 million yuan [4][11]. - The gross margin improved by 1.8 percentage points year-on-year, while the sales expense ratio decreased by 2.8 percentage points year-on-year but increased by 6 percentage points quarter-on-quarter [11]. - R&D expenses reached 31.23 million yuan in Q3 2025, with year-on-year and quarter-on-quarter increases of 5.63 million yuan and 8.37 million yuan, respectively, reflecting the company's commitment to enhancing product capabilities [11]. Product Development and Market Strategy - The company has successfully launched four new products in the Chinese market during the reporting period, continuously improving its product system [11]. - The second-generation super mask, optimized formulas, and new products like the rich cream have gained popularity among consumers, contributing to rapid growth [11]. - The company has opened eight new offline stores in key locations, enhancing its high-end channel presence [11]. Future Outlook - The company expects to achieve net profits attributable to shareholders of 190 million yuan, 300 million yuan, and 380 million yuan for the years 2025, 2026, and 2027, respectively [11].